Investigational Drug Information for Minnelide
✉ Email this page to a colleague
What is the drug development status for Minnelide?
Minnelide is an investigational drug.
There have been 8 clinical trials for Minnelide.
The most recent clinical trial was a Phase 2 trial, which was initiated on April 10th 2017.
The most common disease conditions in clinical trials are Pancreatic Neoplasms, Carcinoma, and Leukemia, Myeloid, Acute. The leading clinical trial sponsors are Minneamrita Therapeutics LLC, National Cancer Institute (NCI), and Queen Mary University of London.
There are two US patents protecting this investigational drug and thirteen international patents.
Summary for Minnelide
| US Patents | 2 |
| International Patents | 13 |
| US Patent Applications | 6 |
| WIPO Patent Applications | 4 |
| Japanese Patent Applications | 2 |
| Clinical Trial Progress | Phase 2 (2017-04-10) |
| Vendors | 14 |
Recent Clinical Trials for Minnelide
| Title | Sponsor | Phase |
|---|---|---|
| Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer | National Cancer Institute (NCI) | Phase 1 |
| Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer | City of Hope Medical Center | Phase 1 |
| Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP) | National Cancer Institute (NCI) | Phase 2 |
Clinical Trial Summary for Minnelide
Top disease conditions for Minnelide
Top clinical trial sponsors for Minnelide
US Patents for Minnelide
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Minnelide | ⤷ Sign Up | C-Myc as a biomarker for tumor sensitivity to treatment with RNA polymerase II inhibition | Institute For Cancer Research (Philadelphia, PA) NexusPharma, Inc. (Philadelphia, PA) | ⤷ Sign Up |
| Minnelide | ⤷ Sign Up | Method of treating MYC-amplified tumors with RNA-polymerase II inhibitors | Institute For Cancer Research (Philadelphia, PA) NexusPharma, Inc. (Langhorne, PA) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Minnelide
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Minnelide | Australia | AU2015413013 | 2035-10-29 | ⤷ Sign Up |
| Minnelide | Canada | CA2977559 | 2035-10-29 | ⤷ Sign Up |
| Minnelide | China | CN107207525 | 2035-10-29 | ⤷ Sign Up |
| Minnelide | Denmark | DK3248981 | 2035-10-29 | ⤷ Sign Up |
| Minnelide | European Patent Office | EP3248981 | 2035-10-29 | ⤷ Sign Up |
| Minnelide | Spain | ES2909799 | 2035-10-29 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
